Delivery Order SPE2DB25D9348-SPE2DB25FNMQU

Award Date 2/12/25
Potential Completion Date 3/6/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,207.70, is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, with a period of performance through February 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,960.00, is for the delivery of Mirena 52 mg systems, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,600.00, is for the delivery of pharmaceutical products, including the Mirena 52 mg system. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,104.00, is for the delivery of Mirena 52 mg systems, a specialized pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $28,176.50 and covers the delivery of MIRENA 52 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance ending on June 6, 2022. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order (SPE2DX15D9363|SPE2DX25F1MNQ) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,920 contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a period of performance through December 5, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,762.36, is for the delivery of MIRENA 52 MG SYSTEMS and has an ultimate completion date of September 19, 2022. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract has a ceiling value of $15,623.10 and a period of performance through February 4, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $15,623.10 and an ultimate completion date of February 4, 2025. The contract is for the delivery of Mirena 52 mg systems, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,368.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MIRENA 52 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance through January 8, 2025. This contract award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
  • SPE2DB25D9348
    Indefinite Delivery Contract
  • SPE2DB25D9348-SPE2DB25FNMQU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $5,207.70 and covers the delivery of Mirena 52 mg systems, a specialized pharmaceutical product, with a completion date of March 6, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

The contract award is not associated with a specific set-aside designation, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through various contract awards.

Generated 5/14/25, 10:40 AM